Capital International LTD Crispr Therapeutics Ag Transaction History

Capital International LTD

$2.09 Billion
Q2 2024

A detailed history of Capital International LTD transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Capital International LTD holds 126,131 shares of CRSP stock, worth $6.4 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

126,131

Previous 126,770 0.5%

Holding current value

$6.4 Million

Previous $8.64 Million 21.16%

% of portfolio

0.33%

Previous 0.43%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$51.17 - $68.18 $32,697 - $43,567	-639 Reduced 0.5%	126,131 $6.81 Million
Q1 2024 May 14, 2024	BUY	$60.67 - $89.12 $1.94 Million - $2.84 Million	31,908 Added 33.64%	126,770 $8.64 Million
Q4 2023 Feb 13, 2024	SELL	$38.62 - $72.18 $4,170 - $7,795	-108 Reduced 0.11%	94,862 $5.94 Million
Q3 2023 Nov 13, 2023	SELL	$45.39 - $59.0 $8,260 - $10,738	-182 Reduced 0.19%	94,970 $4.31 Million
Q2 2023 Aug 11, 2023	BUY	$43.47 - $67.77 $113,804 - $177,421	2,618 Added 2.83%	95,152 $5.34 Million
Q1 2023 May 15, 2023	BUY	$41.0 - $56.12 $583,594 - $798,812	14,234 Added 18.18%	92,534 $4.19 Million
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $86,805 - $145,459	2,215 Added 2.91%	78,300 $3.18 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $1.71 Million - $2.34 Million	27,936 Added 58.02%	76,085 $4.97 Million
Q2 2022 Aug 15, 2022	BUY	$43.23 - $73.83 $212,345 - $362,652	4,912 Added 11.36%	48,149 $2.93 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $198,915 - $315,841	2,838 Added 7.02%	43,237 $3.28 Million
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $49,810 - $70,801	452 Added 1.13%	40,399 $4.52 Million
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $448,838 - $720,572	-4,451 Reduced 10.03%	39,947 $6.47 Million
Q1 2021 May 14, 2021	SELL	$110.72 - $210.04 $2.76 Million - $5.24 Million	-24,951 Reduced 35.98%	44,398 $5.41 Million
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $72,977 - $158,678	916 Added 1.34%	69,349 $10.6 Million
Q3 2020 Nov 13, 2020	BUY	$78.5 - $100.64 $5.37 Million - $6.89 Million	68,433 New	68,433 $5.72 Million

Others Institutions Holding CRSP

# of Institutions

503

Shares Held

57.1M

Call Options Held

1.74M

Put Options Held

1.83M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.96B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

News

Stay updated on Capital International LTD with notifications on news.

Account

Capital International LTD Crispr Therapeutics Ag Transaction History